Dr. Francis Dube on the advancement of mask technologies and ZEN’s graphene based virucidal ink with 99% efficacy

InvestorIntel’s Tracy Weslosky speaks with Dr. Francis Dube, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: ZEN), about ZEN’s novel graphene based virucidal ink. “We have come up with a coating that can be applied to masks and filter membranes to deactivate the COVID-19 virus,” Dr. Dube told InvestorIntel. “It has been proven at plus 99% efficacy through Western University’s ImPaKT facility which is a Biosafety Level 3 lab.”

In an InvestorIntel interview that can also be viewed on our InvestorIntel YouTube channel, Dr. Dube went on to say, while the current mask technologies are only meant to filter out particles, masks sprayed with ZEN’s graphene-based virucidal ink remains 99% effective in killing COVID-19 virus even after 35 days.

To watch the full interview, click here

To learn more about ZEN Graphene Solutions Ltd., click here

Disclaimer: ZEN Graphene Solutions Ltd. is an advertorial member of InvestorIntel Corp.

Disclaimer: The author of this Investor.News post, which is published by InvestorNews Inc., may or may not be a shareholder of any of the companies mentioned in this column. No company mentioned has sponsored or paid for this content on Investor.News, and InvestorNews Inc. does not accept opt-in payments from advertisers. While InvestorNews Inc. provides digital media services like video interviews and podcasts to advertisers, not all are paid promotions. Any sponsored video interview will be clearly marked in the summary. The author of this piece is not a licensed investment advisor and makes no recommendations to buy, sell, or hold any securities. If the author holds an investment advisor license, this will be stated in their biography. Conduct your own due diligence by reviewing public documents of any company. For our full legal notices and disclaimers, click here click here.

Leave a Reply

Your email address will not be published. Required fields are marked *